USD
$0.00
(0.00%
)At Close (As of Sep 15, 2025)
$18.16M
Market Cap
-
P/E Ratio
-43.87
EPS
$30.52
52 Week High
$2.68
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $380K |
Total Revenue | $31M |
Cost Of Revenue | $30M |
Costof Goods And Services Sold | $30M |
Operating Income | -$104M |
Selling General And Administrative | $52M |
Research And Development | $25M |
Operating Expenses | $104M |
Investment Income Net | - |
Net Interest Income | -$1.8M |
Interest Income | $2.1M |
Interest Expense | $289K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $14M |
Income Before Tax | -$112M |
Income Tax Expense | $33K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$112M |
Comprehensive Income Net Of Tax | - |
Ebit | -$112M |
Ebitda | -$97M |
Net Income | -$112M |
Field | Value (USD) |
---|---|
Total Assets | $77M |
Total Current Assets | $39M |
Cash And Cash Equivalents At Carrying Value | $9.2M |
Cash And Short Term Investments | $9.2M |
Inventory | $11M |
Current Net Receivables | $4.8M |
Total Non Current Assets | $37M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $9.7M |
Intangible Assets Excluding Goodwill | $9.7M |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $302K |
Other Current Assets | $14M |
Other Non Current Assets | - |
Total Liabilities | $41M |
Total Current Liabilities | $37M |
Current Accounts Payable | $7M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $24M |
Total Non Current Liabilities | $4M |
Capital Lease Obligations | $6.9M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $27M |
Other Current Liabilities | $4.9M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $35M |
Treasury Stock | - |
Retained Earnings | -$693M |
Common Stock | - |
Common Stock Shares Outstanding | $1.9M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$69M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $14M |
Capital Expenditures | $103K |
Change In Receivables | - |
Change In Inventory | -$587K |
Profit Loss | - |
Cashflow From Investment | $74M |
Cashflow From Financing | -$14M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$112M |
Field | Value (USD) |
---|---|
Gross Profit | $380K |
Total Revenue | $31M |
Cost Of Revenue | $30M |
Costof Goods And Services Sold | $30M |
Operating Income | -$104M |
Selling General And Administrative | $52M |
Research And Development | $25M |
Operating Expenses | $104M |
Investment Income Net | - |
Net Interest Income | -$1.8M |
Interest Income | $2.1M |
Interest Expense | $289K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $14M |
Income Before Tax | -$112M |
Income Tax Expense | $33K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$112M |
Comprehensive Income Net Of Tax | - |
Ebit | -$112M |
Ebitda | -$97M |
Net Income | -$112M |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Bionano Genomics, Inc. is a life science instrumentation company in the genome analysis space. The company is headquartered in San Diego, California.